Plasma cytokines in acute stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 11, Issue 2, 2002, Pages 72-79

  Christensen, Hanne ^a   Boysen, Gudrun ^a   Christensen, Erik ^a   Johannesen, Helle Hjorth ^a   Bendtzen, Klaus ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Acute stroke; Cerebrovascular disease; Cytokines

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE;

EID: 0036522456     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1053/jscd.2002.126688     Document Type: Article

References (49)

1. Rothwell NJ, Loddick SA, Stroemer RP. Interleukins and cerebral ischaemia. Int Rev Neurobiol 1997;40:281-293.
2. Stanimirovic D, Satoh K. Inflammatory mediators of cerebral endothelium: A role in ischemic brain infarction. Brain Pathol 2000;10:113-126.
3. del Zoppo GJ, Ginis I, Hallenbeck JM, et al. Inflammation and stroke: Putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 2000;10:95-112.
4. Tarkowski E, Rosengren L, Blomstrand C, et al. Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol 1997;110:492-499.
5. Tarkowski E, Rosengren L, Blomstrand C, et al. Early intrathecal production of Interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995;26:1393-1398.
6. Ember JA, del Zoppo GJ, Mori E, et al. Polymorphnuclear leukocyte behavior in a nonhuman primate focal ischemia model. J Cereb Blood Flow Metab 1994;14:1046-1054.
7. Beamer NB, Coull BM, Clark WM, et al. Interleukine-6 and interleukine-1 receptor antagonist in acute stroke. Ann Neurol 1995;37(6):800-805.
8. Fassbender K, Rossol S, Kammer T, et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia; Kinetics of secretion and relation to the extend of brain damage and outcome of disease. J Neurol Sci 1994;122:135-139.
9. Kim JS, Yoon SS, Kim YH, et al. Serial measurements of interleukin-, transforming growth factor-β and S-100 protein in patients with acute stroke. Stroke 1996;27:1553-1557.
10. Pelidou S-H, Kostulas N, Matusevicius D, et al. High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases. Eur J Neurol 1999;6:437-442.
11. Vila N, Castillo J, Davalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000;31:2325-2329.
12. Zaremba J, Losy J. Early TNF-α levels correlate with ischaemic stroke severity. Acta Neurol Scand 2001;104:288-295.
13. Carlstedt F, Lind L, Lindahl B. Cytokines measured in a mixed population on arrival in the emergency department are related to mortality and severity and disease. J Intern Med 1997;242:361-365.
14. Wong ML, Bongiorno PB, Gold PW, et al. Localization of interleukin-1-β converting enzyme mRNA in rat brain vasculature: Evidence that the genes encoding the inter-leukin-1 system are constitutively expressed in brain vessels. Pathophysiological implications. Neuroimmunomodulation 1995;2(3):141-148.
15. Corsini E, Dufour A, Ciusani E, et al. Human brain endoithelial cells and astrocytes produce IL-1-β but not IL-10. Scand J Immunol 1996;44(5):506-511.
16. Knerlich F, Schilling L, Görlach C, et al. Temporal profine of expression and cellular localization of inducible nitric oxide synthase, Interleukin-1-β and interleukin converting enzyme after cryogenic lesion of the rat parietal cortex. Brain Res Mol Brain Res 1999;68(1-2):73-87.
17. Stroemer RP, Rothwell NJ. Exacerbation of ischemic brain damage by localized strial injection of interleukin-1-β in the rat. J Cereb Blood Flow Metab 1998;18:833-839.
18. Rothwell NJ, Allan S, Toulmond S. Cytokines and the brain. The role of interleukin-1 in acute neurodegeneration and stroke: Pathophysiological and therapeutical implications. J Clin Invest 1997;100:2648-2652.
19. Loddick SA, Rothwell NJ. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 1996;16:932-940.
20. Allan SM, Parker LC, Collins B, et al. Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat. Proc Natl Acad Sci USA 2000;97(10):5580-5585.
21. Touzani O, Boutin H, Chuquet J, et al. Potential mechanisms of interleukin-1 involvement in cerebral ischemia. J Neuroimmunol 1999;100:203-215.
22. Nawashiro H, Martin D, Hallenbeck JM. Neuroprotektive effects of TNF binding protein in focal cerebral ischemia. Brain Res 1997;778:265-271.
23. Liu T, Clark RK, McDonnel PC, et al. Tumor necrosis factor-α expression in ischemic neurons. Stroke 1994;25:1481-1488.
24. Loetscher H, Steinmetz M, Lesslauer W. Tumor necrosis factor: Receptors and inhibitors. Cancer Cells 1991;3:221-226.
25. Barone FC, Arvin B, White RF, et al. Tumor necrosis factor-α. A mediator of focal ischemic brain injury. Stroke 1997;28(6):1233-1244.
26. Nawashiro H, Martin D, Hallenbech JM. Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cerebr Blood Flow Metab 1997;17(2):229-232.
27. Gary DS, Bruce-Keller AJ, Kindy MS, et al. Ischemic and excitotoxic brain injury is enhanced in mice by lacking the p 55 Tumor Necrosis Factor Receptor. J Cereb Blood Flow Metab 1998;18:1283-1287.
28. Van Wagoner NJ, Benveniste EN. Interleukin-6 expression and regulation in astocytes. J Neuroimmunol 1999;100:124-139.
29. Block F, Peters M, Nolden-Koch M. Expression of IL-6 in the ischemic pernumbra. Neuroreport 2000;11:963-967.
30. Ali C, Nicole O, Docgne F, Lesne S, et al. Ischemia-induced interleukin-6 as a potential endogenious neuroprotective cytokine against MNDA receptor-mediated excitotoxicity in the brain. J Cereb Blood Flow Metab 2000;20:956-966.
31. Loddick SA, Turnball AV, Rothwell NJ. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cerebr Blood Flow Metab 1998;18(2):176-179.
32. Clark WM, Rinker LG, Lessov NS, et al. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 2000;31:1715-1720.
33. Klein DK, White HS, Callahan KS. Cytokine and intra-cellular signaling regulation of tissue factor expression in astrocytes. Neurochem Int 2000;36:441-449.
34. Fuchs AC, Granowitz EV, Shapiro L, et al. Hematologic and immunologic effects of interleukin-10 in humans. J Clin Immunol 1996;16:291-303.
35. Williams K, Dooley N, Ulvestadt E, et al. IL-10 production by adult human derived microglial cells. Neurochem Int 1996;29:55-64.
36. Spera PA, Ellison IA, Feuerstein GZ, et al. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998;251:189-192.
37. Lindenstrom E, Boysen G, Christiansen LW, et al. Reliability of Scandinavian Neurological Stroke Scale. Cerebrovasc Dis 1991;1:103-107.
38. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
39. van der Worp HB, Claus SP, Bär PR, et al. Reproduce- ability of measurements of cerebral infarct volume on CT Scans. Stroke 2001;32:424-428.
40. Svenson M, Hansen MB, Heegaard P, et al. Specific binding of interleukin 1 (IL-1)α and IL-receptor antagonist (IL-lra) to human serum. High-affinity binding of IL-lra to soluble IL-1 receptor type I. Cytokine 1993;5:427-435.
41. Bendtzen K, Hansen MB, Ross C, et al. Cytokines and autoantibodies to cytokines. Stem Cells 1995;13:206-222.
42. Hennig C, Risk L, Fagin U, et al. The influence of naturally occuring heterophilic antiimmunoglobin antibodies on direct measurement of serum proteins using sandwich ELISAs. J Immunol Methods 2000;235:71-80.
43. Boysen G, Christensen H. Stroke severity determines body temperature in acute stroke. Stroke 2001;32:413-417.
44. Beamer NB, Coull BM, Clark WM, et al. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995;37:800-805.
45. Muir KW, Weir CJ, Alwan W, et al. C-reactive protein and outcome after ischemic stroke. Stroke 1999;30:981-985.
46. Murros K, Fogelholm R. Hyperglycemia after stroke: A stress reaction. Stroke 1991;22:692-693.
47. Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001;32:133-138.
48. Grau AJ, Buggle F, Becher H, et al. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res 1996;82(3):245-255.
49. Beamer NB, Coull BM, Clark WM, et al. Persistent inflammatory response in stroke survivors. Neurology 1998;50:1722-1728.